U.S. NeuroSurgical Holdings, Inc.
USNU · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | – | – | – | 50% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Income | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -62.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$1 |
| Pre-Tax Income | -$1 | -$0 | -$0 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$0 | -$1 |
| % Margin | – | – | – | -128.3% |
| EPS | -0.05 | -0.021 | -0.02 | -0.066 |
| % Growth | -142.7% | -2.5% | 69.5% | – |
| EPS Diluted | -0.05 | -0.021 | -0.028 | -0.066 |
| Weighted Avg Shares Out | 22 | 21 | 15 | 15 |
| Weighted Avg Shares Out Dil | 22 | 21 | 15 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | -$0 |
| EBITDA | -$1 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -62.1% |